Iridex (IRIX) Net Margin Growth (3y) (2014 - 2026)

Iridex (IRIX) Net Margin Growth (3y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -388.00
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.00
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -108.00
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1,692.00
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 1,018.00
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 1,978.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 399.00
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Iridex 15.93 Mn 11.33 Mn 4.74 Mn 1,081.00

Historic Data

Download Data
DateValue
Apr 4, 2026 1,081.00
Jan 3, 2026 -4,334.00
Sep 27, 2025 -53.00
Jun 28, 2025 897.00
Mar 29, 2025 369.00
Dec 28, 2024 -964.00
Sep 28, 2024 -37.00
Jun 29, 2024 -3,159.00
Mar 30, 2024 -1,265.00
Sep 30, 2023 588.00
Jul 1, 2023 2,318.00
Apr 1, 2023 305.00
Dec 31, 2022 5,536.00
Oct 1, 2022 466.00
Jul 2, 2022 691.00
Apr 2, 2022 1,091.00
Jan 1, 2022 -8,250.00
Oct 2, 2021 1,083.00
Jul 3, 2021 4,221.00
Apr 3, 2021 2,108.00